N-NOSE is a cancer screening test takes advantage of the keen olfactory sensors of nematodes.
The test will be available to the public in Japan in January 2020.
What is N-NOSE?
Merit of taking a cancer screening test
The world's first biological diagnostic technology.
At Hirotsu Bio Science, we contribute to the development of revolutionary disease diagnostic technologies to lessen your concerns over health.
Message from CEO
List of Officers
Paper on N-NOSE "Behavioural Response Alteration in Caenorhabditis elegans to Urine After Surgical Rem . . .
Hirotsu Bioscience will be on TV Tokyo's "Gaia no Yoake" special features on January 7.
Latest information on CEO Hirotsu's courtesy call on Governor Ogawa of Fukuoka prefecture was in Nikkei BP's Bey . . .
On December 17, CEO Hirotsumade a courtesy call on Governor Ogawa of Fukuoka prefecture to report the launch of . . .
On December 7, CEO Hirotsu gave a special lecture at 357th The Japanese Society of Gastroenterology.
N-NOSE was introduced in Nihon TV's "Sekaiichi Uketai Jugyo" on December 7.
Interview of CEO Hirotsy was in yomiDr., Yomiuri Shimbun's medical and healthcare information website.
. . .
Running story about CEO Hirotsu started in Nikkei Sangyo Shimbun from Novemver 25, 2019 (total 16 articles). . . .
At 27th Japan Digestive Disiese Week (JDDW 2019 KOBE), subjects on N-NOSE clinical research will be presented by . . .
This paper is the first report on the possibility that our cancer test N-NOSE could be applied to non-human ani . . .
The world’s first cancer screening using biological diagnostic technology